Peter K. Working

Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma

Donald W. Northfelt, Francis J. Martin, Peter K. Working et al. · The Journal of Clinical Pharmacology · 1996 · 375 citations

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice

Mary S. Newman, Gail Colbern, Peter K. Working et al. · Cancer Chemotherapy and Pharmacology · 1999 · 273 citations

Oncology, Medicine, Tumor Targeting +7

A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer

Eric J. Small, Michael A. Carducci, James M. Burke et al. · Molecular Therapy · 2006 · 243 citations · Full text

Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts

Jan Vaage, Emilio Barberá‐Guillem, R.M. Abra et al. · Cancer · 1994 · 165 citations

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

William C. Zamboni, Anne Gervais, Merrill J. Egorin et al. · Cancer Chemotherapy and Pharmacology · 2004 · 163 citations

Tumor Disposition, Medicine, Melanoma +9